According to Galectin Therapeutics's latest financial reports the company's current earnings (TTM) are -S$57.69 M. In 2023 the company made an earning of -S$53.5 M a decrease over its 2022 earnings that were of -S$50.51 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.